Metabolic control in diabetic patients at the primary care level in Mexico

Diabetes Research and Clinical Practice

Volumn 37, Issue 3, 1997, Pages 179-184

  Peña Valdovinos, Abel ^a   Jiménez Cruz, Arturo ^b,c   Leyva Pacheco, Rodolfo ^b   Bacardi Gascon, Montserrat ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c NONE   (United States)

Author keywords

Diabetes mellitus; Metabolic control; Primary care level

Indexed keywords

ANTIDIABETIC AGENT; CHLORPROPAMIDE; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TOLBUTAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MEXICO; OUTPATIENT CARE; PATIENT COUNSELING; PRIMARY MEDICAL CARE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MEXICO; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0343488859     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00075-2     Document Type: Article

References (21)

1. S.M. Haffner, H.P. Hazuda, B.D. Mitchell, J.K. Patterson, M.P. Stern, Increased incidence of type II diabetes mellitus in Mexican Americans, Diabetes Care 14 (2) (1991) 102-108.
2. H. King, Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults, Diabetes Care 16 (1) (1993) 157-177.
3. M.P. Stern, C. González, B.D. Mitchell, E. Villalpando, S.M. Haffner, H.P. Hazuda, Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio, Diabetes 41 (1992) 484-492.
4. L.I. Gardner, M.P. Stern, S.M. Haffner, S.P. Gaskill, H.P. Hazuda, J.H. Relethford, C.W. Eifler, Prevalence of diabetes in Mexican Americans, relationship to percent of gene pool derived from native American sources, Diabetes 33 (1984) 86-92.
5. C.V. González, M.P. Stern, E. Villalpando, H. Hazuda, S.M. Haffner, E. Lisci, Prevalencia de diabetes e intolerancia a la glucosa en una población urbana de nivel económico bajo, Rev. Inv. Clin. 44 (3) (1992) 321-329.
6. P. Vaughan, L. Gilson, A. Mills, Diabetes in developing countries: its importance for public health, Health Policy Plann. 4 (2) (1989) 97-109.
7. E.D. Bransome, Financing the care of diabetes mellitus in the U.S., Diabetes Care 15 (1) (1992) 1-5.
8. Center of Economic Studies in Medicine. Direct and indirect costs of diabetes in the United States in 1992. Alexandria, Virgina: American Diabetes Association; 1993.
9. Rubin, R.J., Altman, W.M., Mendelson, D.N. Health care expenditures for people with diabetes mellitus, J. Clin. Endocrinol Metab. 78 (1994) 809A-F.
10. G. Fajardo, Diabetes mellitus. Sus costos directes. IMSS, 1990, Rev. Med. IMSS 30 (1992) 115-117.
11. The Diabetes Control and Complications Trial Research Group, The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin- dependent diabetes mellitus: the Diabetes Control and Complications Trial, N. Engl. J. Med. 329 (1993) 977-986.
12. M. Tuttleman, L. Lipsett, M. Harris, Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients, Diabetes Care 16 (5) (1993) 765-772.
13. American Diabetic Association, Standards of medical care for patients with diabetes mellitus, Diabetes Care 17 (1994) 616-623.
14. A. Peña-Valdovinos, A. Jiménez-Cruz, M. Bacardí-Gascón, Conocimiento y aplicación de los critérios diagnósticos de diabetes mellitus, J. Border Health 2 (1) (1997) 19-24.
15. Secretaria de Salud. Norma Oficial Mexicana para la Prevención, tratamiento y control de la diabetes mellitus en la atención primaria. Diario Oficial, viernes 3 de junio de 1994.
16. American Diabetic Association, Implications of the Diabetes Control and Complications Trial (Position Statement), Diabetes 42 (1993) 1555-1558.
17. J.P. Weiner, S.T. Parente, D.W. Garnick, J. Fowles, A.G. Lawthers, R.H. Palmer, Variation in office-based quality, a claims-based profile of care provided to Medicare patients with diabetes, J. Am. Med. Assoc. 273 (19) (1995) 1503-1508.
18. The DCCT Research Group, Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial, Am. J. Cardiol. 75 (1995) 894-903.
19. R. Glasgow, A practical model of diabetes management and education, Diabetes Care 18 (1) (1995) 117-126.
20. The Diabetes Control Complications Trial Research Group, The effect of intensive diabetes therapy on the development and progression of neuropathy, Ann. Inter. Med. 122 (8) (1994) 561-568.
21. P. Wang, J. Lau, T. Chalmers, Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes, Lancet 341 (1993) 1306-1309.